Can-Fite BioPharma Ltd. Cash And Cash Equivalents At Carrying Value

• Can-Fite BioPharma Ltd. showed an increase of +14.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from Can-Fite BioPharma Ltd.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
• XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 9 years of available data (2017 to 2025), Can-Fite BioPharma Ltd.'s Cash And Cash Equivalents At Carrying Value has grown by 57.7%.
• Historical annual values: Fiscal year 2025: $5.53 million | Fiscal year 2024: $4.83 million | Fiscal year 2023: $4.28 million | Fiscal year 2022: $2.98 million | Fiscal year 2021: $4.39 million | Fiscal year 2020: $8.27 million | Fiscal year 2019: $2.70 million | Fiscal year 2018: $3.62 million | Fiscal year 2017: $3.51 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026